Pablo Lores Lareo
Company: Sylentis
Job title: CMC Director
Seminars:
Innovation in therapeutic-oligonucleotide manufacturing to sustainably meet future demand 9:30 am
Pursuing a zero-waste strategy that meets Sustainable Development Goals (SDG) in oligonucleotide manufacturing Designing and building the future plant: achieving BREEAM certification Case study: purification resin substitutionRead more
day: Conference Day Two